Physician profile
David A Robison
NPI 1770891210
$1,235.71
in general payments reported to CMS, 2019-2025
23 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $684 · 2023: $90.21 · 2024: $63.71 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.97 | 2021-2025 | |
| Novo Nordisk INC | $206.34 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $85.44 | 2022-2024 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.70 | 2021-2023 | Stiolto Respimat |
| Merck Sharp & Dohme LLC | $66.94 | 2021-2022 | |
| Amgen INC. | $49.83 | 2021-2022 | |
| Cranial Technologies, INC | $49.23 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $45.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.11 | 2021-2023 | |
| Pfizer INC. | $36.55 | 2022 | |
| Lilly USA, LLC | $31.86 | 2021-2022 | |
| Organon LLC | $25.11 | 2024-2025 | Nexplanon |
| Idorsia Pharmaceuticals US INC | $22.80 | 2022 | |
| Janssen Biotech, INC. | $20.77 | 2022 | |
| Axsome Therapeutics, INC. | $19.15 | 2025 | Auvelity |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.98 | 2022 | |
| Edwards Lifesciences Corporation | $17.04 | 2022 | |
| Sanofi Pasteur INC. | $16.50 | 2022 | |
| Xeris Pharmaceuticals, INC. | $16.27 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.12 | 2021 | |
| Glaxosmithkline, LLC. | $13.48 | 2022 | |
| Viiv Healthcare Company | $11.84 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $10.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Robison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.